Laiyu Liu

机构：Nanfang Hospital, Southern Medical University · ORCID：0000-0001-5827-0802

发表论文 101 篇 · 总被引 1871 次 · h-index 21

代表论文

• Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant (2024 · JAMA · 被引 188)
• Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer (2024 · JAMA Oncology · 被引 65)
• Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial (2026 · The Lancet · 被引 20)
• Variations in salivary microbiome and metabolites are associated with immunotherapy efficacy in patients with advanced NSCLC (2025 · mSystems · 被引 15)
• Bongkrekic acid alleviates airway inflammation via breaking the mPTP/mtDAMPs/RAGE feedback loop in a steroid-insensitive asthma model (2024 · Biomedicine & Pharmacotherapy · 被引 9)
• MK-1084 for KRAS G12C-mutated (mut) metastatic non–small-cell lung cancer (mNSCLC): Results from KANDLELIT-001. (2025 · Journal of Clinical Oncology · 被引 8)